MedTrace Logo

Effect of Calanus Oli on Intra-abdominal Fat, Glucose Tolerance and Lipids in Man

NCT01193543 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2012-09-05

No results posted yet for this study

Summary

Preliminary studies in rats and mice indicate that calanus oil reduce accumulation of intra-abdominal fat. Pilot studies in humans have shown no adverse effects. In the present study 120 subjects, males and females, 20-65 years old, BMI 25-30 kg/m2 will be included and given calanus oli 1 g twice daily versus placebo for 1 year. The hypothesis is that calanus oil will reduce intra-abdominal fat, improve glucose tolerance and lipid profile.

Conditions

Interventions

DIETARY_SUPPLEMENT

calanus oil

1 gram twice daily

DIETARY_SUPPLEMENT

olive oil

1 gram twice daily

Sponsors & Collaborators

  • University of Tromso

    lead OTHER

Principal Investigators

  • Rolf Jorde, Professor · University of Tromso

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2012-06-30
Completion
2012-08-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01193543 on ClinicalTrials.gov